Infusional FOLFOX Plus Camrelizumab & Apatinib vs HAIC-FOLFOX Plus

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06376604` - Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies	N/A
Completed	`NCT03753542` - Effect of Nurse-led Education on Parent's Anxiety and Depression on Managing Side Effects of Chemotherapy	N/A
Not yet recruiting	`NCT05022628` - Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis	Phase 4
Completed	`NCT04207359` - Effects of Creatine Supplementation in Breast Cancer Survivors	N/A
Recruiting	`NCT04489173` - TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer	Phase 2
Completed	`NCT04173195` - Comfort Talk (CT) During Outpatient Chemotherapy	N/A
Recruiting	`NCT06041477` - Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC	Phase 3
Recruiting	`NCT05014399` - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Recruiting	`NCT03275194` - HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy	Phase 2
Recruiting	`NCT04808466` - Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy	Phase 2
Completed	`NCT05131490` - Effect on Adaptation to Cancer of Mobile Application Developed for Gynecological Cancer Patients	N/A
Completed	`NCT04118322` - The Effect of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy	N/A
Recruiting	`NCT06043999` - Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients	N/A
Recruiting	`NCT05515796` - Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors	Phase 2
Not yet recruiting	`NCT04845490` - Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy	Phase 2
Recruiting	`NCT04989985` - S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma	Phase 2
Recruiting	`NCT05992337` - New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.
Recruiting	`NCT05424692` - Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer	N/A
Enrolling by invitation	`NCT04027478` - Can Fasting Decrease the Side Effects of Chemotherapy?	N/A
Completed	`NCT04116138` - Antisecretory Factor in Primary Glioblastoma 1	Phase 1/Phase 2

NCT number	NCT06172205
Study type	Interventional
Source	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Contact	Yunxiuxiu Xu, MD
Phone	17722864609
Email	xuyxx@mail.sysu.edu.cn
Status	Recruiting
Phase	Phase 3
Start date	July 1, 2023
Completion date	July 31, 2027

Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms